Anzeige
Mehr »
Donnerstag, 24.07.2025 - Börsentäglich über 12.000 News
Neubewertung voraus? Wird die Aktivierung der EU-Lizenz zum Kurs-Katalysator für die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18.06.Fired ACIP panel says RFK Jr is weakening vaccine programmes
18.06.UK regulator overhauls medical device regulation
18.06.Welsh biotech Draig emerges with $140m in financing
18.06.FDA unveils fast-track review path for 'national priorities'
17.06.23andMe fined £2.31m over UK users' genetic data breach
17.06.FDA green lights CSL's once-monthly HAE drug Andembry
17.06.Update: Rumour confirmed as Lilly buys Verve Therapeutics
17.06.Caris swells its planned IPO, seeking $5.7bn valuation
17.06.Is Lilly about to swoop on Verve Therapeutics?
17.06.Genentech's Bittenbender named board chair at BIO
16.06.After rebuffing Biogen, Sage pairs off with Supernus
16.06.J&J says two drugs are better than one in pretreated myeloma
16.06.Former CEO wins bidding war for 23andMe, beating Regeneron
16.06.DMD gene therapy Elevidys linked to new liver failure case
16.06.Streeting pledges clinical trial signups in the NHS App
13.06.US lawmakers seek ban on DTC advertising
13.06.AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance
13.06.Moderna's RSV shot gets US nod for use in younger adults
13.06.Pushback rises against RFK Jr's new ACIP membership
13.06.NHS starts first national rollout of Blenrep for myeloma
13.06.Data at EULAR back Biogen, UCB's first-in-class lupus drug
12.06.BioNTech to buy rival mRNA firm CureVac for $1.25bn
12.06.MSD aims to plug dengue fever vaccine gap in US
12.06.FDA clears Nuvation's first product Ibtrozi, for lung cancer
12.06.Novo Nordisk teams up with NVIDIA on AI models